Incidence of histoplasmosis in patients receiving TNF-alpha inhibitors: A systematic review and meta-analysis

Murillo M. Cipolat,Débora R.R. Rodrigues,Claiton V. Brenol,Alessandro C. Pasqualotto,Diego R. Falci
DOI: https://doi.org/10.1097/md.0000000000036450
IF: 1.6
2024-02-23
Medicine
Abstract:Endemic fungal diseases represent a heterogeneous group of neglected infections that are generally characterized by limited diagnostic and therapeutic options, especially in developing countries. In this category, histoplasmosis is considered endemic in the United States (US) Midwest and many regions of Central and South America, as well as in Asia and Africa. [ 1–3 ] Histoplasmosis is the disease caused by the dimorphic fungus Histoplasma capsulatum , which can range from an asymptomatic infection to a systemic disease that, in the disseminated form, has an important possibility of progressing to death. The disease is regarded as one of the most common endemic mycoses in HIV-infected patients in those areas, causing high morbidity and mortality. [ 4 ] Ninety-five percent (95%) of patients with acquired immunodeficiency syndrome (AIDS) and H capsulatum infection develop disseminated disease, with 90% having CD4 counts below 200 cells/mm 3 at the time of diagnosis. [ 5 ] In the US, state-specific annual incidence rates ranged from 0 to 4.3 cases/100,000 population, with the highest rates found in cities in endemic areas, including the Ohio and Mississippi River valleys. [ 6 ]
medicine, general & internal
What problem does this paper attempt to address?